Haselmeier and Common Sensing will create a new solution for injectable medicines

| By | Medical Devices

Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based (USA) smart injector monitoring and support solutions company, announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines.

Worldwide, over 16 billion injections of medicine are administered every year. Smart connected monitoring solutions for users of injectables is aimed helping them to properly administer those medicines to improve efficacy and quality of therapies.

Haselmeier’s subcutaneous drug delivery injection systems for self-administration will be
combined with Common Sensing’s Gocap injector monitoring technology, creating a first-of-itskind, next generation, smart disposable injector pen platform, to be available in 2019. This platform will be sold by Haselmeier and is expected to drive significant interest from new and existing Haselmeier injector customers. The combined injector pen-Gocap platform will record the time and amount of every injector dose, along with other information like storage temperature.

Haselmeier has a history of developing innovative mechanical drug delivery solutions, including Haselmeier’s most recent and innovative D-Flex injector, which may be used with both fixed-dose or selectable dose regimen. The addition of a custom-designed Gocap injector monitor to the Haselmeier product portfolio will allow pharmaceutical customers to quickly launch connected injectable medicines into the market with existing and new Haselmeier pens.

SOURCE: haselmeier
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.